Skip to main content

Animations

MJFF Publications

8131 - 8140 of 8511 Results
Title
Year
  • Year
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • 2011
  • Summary Details
    OPEN
    Title: Parkinson's disease, cortical dysfunction, and alpha‐synuclein
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23697
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Abnormal calcium homeostasis and protein folding stress at the ER
    Journal Name: Communicative & Integrative Biology
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.4161/cib.4.3.15019
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
    Journal Name: Journal of Neural Transmission
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00702-011-0653-2
    Best OA location URL:
    Citation Count: 261
  • Summary Details
    OPEN
    Title: Pre- and post-synaptic cortical cholinergic deficits are proportional to amyloid plaque presence and density at preclinical stages of Alzheimer’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-011-0831-1
    Citation Count: 92
  • Summary Details
    RESTRICTED
    Title: Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson’s Disease
    Journal Name: Journal of Movement Disorders
    Publisher: The Korean Movement Disorder Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.14802/jmd.11001
    Citation Count: 15
  • Summary Details
    RESTRICTED
    Title: Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.23737
    Citation Count: 36
  • Summary Details
    RESTRICTED
    Title: Priorities in Parkinson's disease research
    Journal Name: Nature Reviews Drug Discovery
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/nrd3430
    Best OA location URL:
    Citation Count: 369
  • Summary Details
    OPEN
    Title: Group patient visits for Parkinson disease
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182194bad
    Citation Count: 22
  • Summary Details
    RESTRICTED
    Title: Biomarkers for Parkinson’s Disease
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488
    Best OA location URL:
    Citation Count: 42
  • Summary Details
    RESTRICTED
    Title: Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors
    Journal Name: Pharmacological Research
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.phrs.2011.03.017
    Best OA location URL:
    Citation Count: 52
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.